SavedAdd your journal

Journals / Erciyes Medical Journal / 2020 / Cilt: 42 - Sayı: 1

Neoadjuvant Doxorubicin and Docetaxel in Breast Cancer Patients Applied Neutropenic Enterocolitis

Hatice Aslan SIRAKAYA
Mevlüde İNANÇ
Pages
108–109
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a case of a 38 year old female patient with breast cancer who received doxorubicin and docetaxel and presented typhlitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neutropenic enterocolitis is an acute complication of neutropenia induced by chemotherapy, characterized by inflammatory processes involving the colon and cecum that can lead to necrosis, hemorrhage, perforation, and septicemia.
📊
Key Findings & Data:Usually, this condition develops after use of cytotoxic drugs, and fever and abdominal pain are the main symptoms.
💡
Conclusion & Impact:We present a case of a 38 year old female patient with breast cancer who received doxorubicin and docetaxel and presented typhlitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Neutropenic enterocolitis is an acute complication of neutropenia induced by chemotherapy, characterized by inflammatory processes involving the colon and cecum that can lead to necrosis, hemorrhage, perforation, and septicemia. Usually, this condition develops after use of cytotoxic drugs, and fever and abdominal pain are the main symptoms. We present a case of a 38 year old female patient with breast cancer who received doxorubicin and docetaxel and presented typhlitis.

🔖

Cite This Article

SIRAKAYA, H. A., İNANÇ, M. (2020). Neoadjuvant Doxorubicin and Docetaxel in Breast Cancer Patients Applied Neutropenic Enterocolitis. Erciyes Medical Journal, Cilt: 42 - Sayı: 1, 108–109. https://ajindex.com/articles/210282

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Portugal R, Nucci M. Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review. Expert Rev Hematol 2017; 10(2): 169– 74
  2. Rochigneux P, Schleinitz N, Ebbo M, Aymonier M, Pourroy B, Boissier R, et al. Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature review. Anticancer Drugs 2018; 29(5): 477–81
  3. Duceau B, Picard M, Pirracchio R, Wanquet A, P ène F, Merceron S, et al. Neutropenic Enterocolitis in Critically Ill Patients: Spectrum of the Disease and Risk of Invasive Fungal Disease. Crit Care Med 2019; 47(5): 668–76
  4. Dumitra S, Sideris L, Leclerc Y Leblanc G, Dub é P. Neutropenic enterocolitis and docetaxel neoadjuvant chemotherapy. Ann Oncol 2009; 20(4): 795–6
  5. Oehadian A, Fadjari TH. Neutropenic enterocolitis in breast cancer patient after taxane–containing chemotherapy. Acta Med Indones 2008; 40(1): 29–33
  6. Rodrigues FG, Dasilva G, Wexner SD. Neutropenic enterocolitis. World J Gastroenterol 2017; 23(1): 42–7
  7. Vergara-Fern ández O, Trejo-Avila M, Sol órzano-Vicu ña D, Santes O, Salgado-Nesme N. Factors associated with emergent colectomy in patients with neutropenic enterocolitis. Langenbecks Arch Surg 2019; 404(3): 327–34
  8. Youngs J, Suarez C, Koh MBC. An unusual presentation of neutropenic enterocolitis (typhlitis). Lancet Infect Dis 2016; 16(5): 618
  9. Mourad N, Michel RP, Marcus VA. Pathology of Gastrointestinal and Liver Complications of Hematopoietic Stem Cell Transplantation. Arch Pathol Lab Med 2019; 143(9): 1131–43
  10. Rolston KV. Infections in Cancer Patients with Solid Tumors: A Review. Infect Dis Ther 2017; 6(1): 69–83.